These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8915678)

  • 1. V beta specificity of superantigen TSST-1 plus CD28 costimulation without APCs.
    Hu WG; Zhu XH
    Immunol Invest; 1996; 25(5-6):405-11. PubMed ID: 8915678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of a T-cell epitope of superantigen toxic shock syndrome toxin 1 to residues 125 to 158.
    Hu WG; Zhu XH; Wu YZ; Jia ZC
    Infect Immun; 1998 Oct; 66(10):4971-5. PubMed ID: 9746605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA; Shah V; Klein N; Dillon MJ
    Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A co-stimulatory role for CD28 in the activation of CD4+ T lymphocytes by staphylococcal enterotoxin B.
    Goldbach-Mansky R; King PD; Taylor AP; Dupont B
    Int Immunol; 1992 Dec; 4(12):1351-60. PubMed ID: 1363054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against lethal toxic shock by targeted disruption of the CD28 gene.
    Saha B; Harlan DM; Lee KP; June CH; Abe R
    J Exp Med; 1996 Jun; 183(6):2675-80. PubMed ID: 8676089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
    Dennig D; O'Reilly RJ
    J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V beta 11+ T-lymphocyte expansion by toxic shock syndrome toxin-1 differs in mice bearing H-2q versus H-2b haplotypes.
    Zhao YX; Brunsberg U; Holmdahl R; Tarkowski A
    Immunology; 1998 May; 94(1):1-4. PubMed ID: 9708179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
    J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1.
    Kum WW; Hung RW; Cameron SB; Chow AW
    J Infect Dis; 2002 Feb; 185(4):555-60. PubMed ID: 11865410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
    Norton SD; Schlievert PM; Novick RP; Jenkins MK
    J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion.
    Jackow CM; Cather JC; Hearne V; Asano AT; Musser JM; Duvic M
    Blood; 1997 Jan; 89(1):32-40. PubMed ID: 8978274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock.
    Arad G; Levy R; Nasie I; Hillman D; Rotfogel Z; Barash U; Supper E; Shpilka T; Minis A; Kaempfer R
    PLoS Biol; 2011 Sep; 9(9):e1001149. PubMed ID: 21931534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
    Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
    J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation.
    Mingari MC; Cambiaggi A; Vitale C; Schiavetti F; Bellomo R; Poggi A
    Int Immunol; 1996 Feb; 8(2):203-9. PubMed ID: 8671605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the early response to TSST-1 reveals Vbeta-unrestricted extravasation, compartmentalization of the response, and unresponsiveness but not anergy to TSST-1.
    Waclavicek M; Stich N; Rappan I; Bergmeister H; Eibl MM
    J Leukoc Biol; 2009 Jan; 85(1):44-54. PubMed ID: 18923105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The toxic shock syndrome toxin-1 induces anergy in human T cells in vivo.
    Mahlknecht U; Herter M; Hoffmann MK; Niethammer D; Dannecker GE
    Hum Immunol; 1996 Jan; 45(1):42-5. PubMed ID: 8655359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.